Golden
Second Genome

Second Genome

A company developing microbiome modulators for infection, immunity and metabolic diseases

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

June 5, 2013

Second Genome raises a $11,500,000 series A round from Morgenthaler Ventures and Advanced Technology Ventures.

Funding rounds

Funding round
Funding round amount (USD)
Funding type
Funding round date
Investment
2 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Adam Altrichter

Employee



Ali A. Faruqi

Employee



Amit Bansal

Investor



Andrew Han

Employee



Anh Vu

Employee



Bettina John

Employee



Cara Cheng

Employee



Daniel Morton

Employee



Darren Tsang

Employee



Drew Taylor

Investor



Gregory Tang

Employee



Inessa O-Childs

Investor



Kaitlin Flynn

Employee



Paul Connors

Investor



Steven McColloch

Employee



Sunit Jain

Employee



Taru G

Employee



Tuff Yen

Investor



Tyler Dorman

Investor



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services